Sandoz US CCO Calls For Authorized Generic Omission From IRA
Tim DeGavre Also Highlighted Upcoming Opportunities For Generics Giant
Executive Summary
The Inflation Reduction Act should take a different approach when it comes to authorized generic products, Sandoz US chief commercial officer Tim DeGavre has told Generics Bulletin.